|
|
Article: Merck studies on Vioxx questioned in leading medical journal
- Article from:
- International Herald Tribune
- Article date:
- April 17, 2008
- Author:
CopyrightProvided by ProQuest LLC. (Hide copyright information)
|
Stephanie Saul The New York Times Media Group
International Herald Tribune
04-17-2008
Merck studies on Vioxx questioned in leading medical journal
Byline: Stephanie Saul The New York Times Media Group
Edition: 4
Section: FINANCE/BUSINESS
NEW YORK --
The drug maker Merck drafted dozens of research studies for a best-selling drug, then lined up prestigious doctors to put their names on the reports before publication, according to an article published Wednesday in a leading medical journal.
The article, based on documents unearthed in lawsuits over the pain drug Vioxx, provides a rare, detailed look at the industry practice of ghostwriting medical research studies that are then published in ...
Related newspaper, magazine, and journal articles:
|
|
Article: Pro-Fluoridation Studies Faulty, Reports British Medical ...
PR Newswire;
October 11, 2000 ;
700+ words
... ... wrist fractures, reports the British Medical Journal (B.M.J.), October 7, 2000 ... St. Lawrence University, Canton, New York. "When dental fluorosis occurs, it ... President and General Counsel to the New York State Coalition Opposed to Fluoridation ...
|
|